The Peptide Audit

What is CJC-1295 (with DAC)?

Human clinical studiesGH Secretagogues research · Last reviewed September 28, 2026

CJC-1295 with DAC is a GHRH analogue attached to a “drug affinity complex” that binds albumin in the blood.

How does CJC-1295 (with DAC) work?

Binding to albumin greatly extends its life in the body, producing a sustained rise in growth hormone and IGF-1 rather than short pulses.

What are researchers studying?

Where does the evidence stand?

Human clinical studies

Early human studies were published in the mid-2000s; development did not lead to an approved drug. Prohibited in sport by WADA.

Quick facts

Research area
GH Secretagogues
Also known as
CJC-1295 w/ DAC, CJC-1295 with DAC, CJC w/ DAC
Third-party lab results
2 published COAs →
Tested vendors tracking it
1 vendor →

Compare CJC-1295 (with DAC)

Related research guides

Free weekly email
Get The Peptide Audit Weekly

Every Monday: the week's price drops and restocks, new third-party lab results, and a plain-English research guide with the latest studies. No spam — unsubscribe anytime.

This guide summarizes published research for educational purposes only. It is not medical advice and does not describe how to use CJC-1295 (with DAC). Citations link to PubMed and are listed for reference — we haven't reviewed or endorsed their findings. Products referenced on The Peptide Audit are sold by third parties for laboratory research use only and are not for human consumption.